Skip to main content
. Author manuscript; available in PMC: 2020 May 23.
Published in final edited form as: J Med Chem. 2019 May 9;62(10):4967–4978. doi: 10.1021/acs.jmedchem.9b00068

Figure 6.

Figure 6.

In vitro inhibitory activities of HCS-4E-BP1 and -eIF4G peptides as determined via PPI cat-ELCCA. (A) Inhibition of the eIF4E—4E-BP1 PPI by 4E-BP1, HCS-4E-BP1, and HCS-4E-BP1 (LMAA) peptides; and (B) eIF4G, HCS-eIF4G, linear sTIP-04, and sTIP-04 peptides. (C) Table of IC50 values presented as 95% confidence intervals.